Comparison of early and delayed cholecystectomy for biliary pancreatitis: A meta-analysis

Early versus delayed cholecystectomy in biliary pancreatitis: Experience from a Local Acute Care Surgery Unit in Saudi Arabia

Biliary pancreatitis is a common complication of gallstones. Although most patients experience mild disease, around 20% may develop severe pancreatitis with an increased risk of serious complications during recurrent attacks. The objective of our study is to compare the surgical outcomes and length of stay for early versus delayed cholecystectomy, performed within the same admission, for mild pancreatitis in a Saudi tertiary center with an established Acute Care Surgey Unit. This retrospective cohort study included all patients who underwent cholecystectomy during the index admission for biliary pancreatitis between January 2017 and January 2020. Surgical outcomes and hospital length of stay were collected and analyzed to assess overall outcomes for early and delayed cholecystectomy groups. The early group was defined as surgery performed within 72 hours of presentation. Eighty-six patients were included and allocated to the early and delayed cholecystectomy groups. The median length of hospital stay was significantly shorter in the early cholecystectomy group (4 days, IQR 3-5) compared to the delayed group (7 days, IQR 6-9) (P < .001). There was no significant difference in operative time and postoperative complications. Early cholecystectomy for mild biliary pancreatitis appears safe and feasible and may result in a shorter hospital stay.

coMpliAnce with evideNce-based cliniCal guidelines in the managemenT of acute biliaRy pancreAtitis): The MANCTRA-1 international audit

BACKGROUND/OBJECTIVES

Reports about the implementation of recommendations from acute pancreatitis guidelines are scant. This study aimed to evaluate, on a patient-data basis, the contemporary practice patterns of management of biliary acute pancreatitis and to compare these practices with the recommendations by the most updated guidelines.

METHODS

All consecutive patients admitted to any of the 150 participating general surgery (GS), hepatopancreatobiliary surgery (HPB), internal medicine (IM) and gastroenterology (GA) departments with a diagnosis of biliary acute pancreatitis between 01/01/2019 and 31/12/2020 were included in the study. Categorical data were reported as percentages representing the proportion of all study patients or different and well-defined cohorts for each variable. Continuous data were expressed as mean and standard deviation. Differences between the compliance obtained in the four different subgroups were compared using the Mann-Whitney U, Student's t, ANOVA or Kruskal-Wallis tests for continuous data, and the Chi-square test or the Fisher's exact test for categorical data.

RESULTS

Complete data were available for 5275 patients. The most commonly discordant gaps between daily clinical practice and recommendations included the optimal timing for the index CT scan (6.1%, χ2 6.71, P = 0.081), use of prophylactic antibiotics (44.2%, χ2 221.05, P < 0.00001), early enteral feeding (33.2%, χ2 11.51, P = 0.009), and the implementation of early cholecystectomy strategies (29%, χ2 354.64, P < 0.00001), with wide variability based on the admitting speciality.

CONCLUSIONS

The results of this study showed an overall poor compliance with evidence-based guidelines in the management of ABP, with wide variability based on the admitting speciality. Study protocol registered in ClinicalTrials.Gov (ID Number NCT04747990).

[Treatment of acute pancreatitis from the viewpoint of surgery]

The role of surgery in the treatment of acute pancreatitis has clearly changed over the years. In the 1990s a clear reduction in hospital mortality was achieved through surgery, whereas the value of surgery (open, in general) has slipped into the background due to the improvement in intensive care medicine in general and the development of minimally invasive treatment options. Nowadays, patients with acute pancreatitis are only operated on after exhaustion of intensive medical care treatment and minimally invasive interventions or when complications occur that cannot be treated in any other way (e.g. hollow organ perforation). This article provides an overview of the currently used treatment measures.

Long-term outcome of patients with biliary pancreatitis not undergoing cholecystectomy. A retrospective study

BACKGROUND AND OBJECTIVE

Most acute pancreatitis are of biliary origin and undergoing a cholecystectomy is recommended to prevent recurrence. However, some patients will never be referred to surgery. We reviewed the long-term follow-up of these group of patients Methods All cases of biliary pancreatitis presented from January 2015 to December 2017 that did not receive a cholecystectomy were analyzed. Epidemiologic data and Charlson comorbidity Index (CCI) were recorded. Recurrent episodes of pancreatitis or biliary events and mortality during the follow-up period was recorded. Results A total of 104 patients were included in the study (30.4% of all biliary pancreatitis). Median age was 82 years (range 27-96). Average CCI was 5 (range 0-18). The median follow-up period was 37 months (range 1-70). A total of 41 patients (39.4%) had gallstone-related complications. Twenty-three patients (22,1%) had recurrent pancreatitis and 34 (32,7%) developed biliary events. Decease occurred in 25 patients during follow-up (24%) but only 6 (5,8%) were due to gallstone-related complications. Non-related mortality was 15.5% in patients who refused surgery and 25% if high comorbidity patients.

CONCLUSION

Patients that are not cholecystectomized are at high risk for biliary event and pancreatitis recurrence. Conservative treatment and surgical abstention should be individualized and reserved to high comorbid patients with short life expectancy.